Singapore, Feb. 24 -- Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer, key to boosting survival rates, will begin at The University of Queensland (UQ) this year.

Researchers will confirm the performance of UQ's test for ovarian cancer in the general population as a screening tool for the disease, dubbed 'the silent killer'.

Professor Carlos Salomon Gallo,Director of theUQ Centre for Extracellular Vesicle Nanomedicine,said around 1,500 women from across Queensland will be recruited to take part in this ground-breaking study to determineits suitability for population-based screening for ovarian cancer.

In this study, researchers will confirm the performance of the test under real-world conditions ...